The FDA has approved Nova Eye Medical's iTrack Advance device for canal-based glaucoma surgery in the US.
The iTrack Advance is a high-precision handheld delivery system for injecting viscoelastic fluid into the eye's main drainage canal, aiming to treat glaucoma by clearing blockages that cause elevated eye pressure.
The device appeals to glaucoma and cataract surgeons as well as comprehensive surgeons and can be used for standalone procedures or combined with cataract surgery.
Nova Eye plans a full product launch at the American Society of Cataract and Refractive Surgery conference in San Diego on May 5-8, 2023.